TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $285,000 | -42.9% | 15,000 | 0.0% | 0.18% | -45.9% |
Q3 2021 | $499,000 | -14.3% | 15,000 | 0.0% | 0.34% | -2.3% |
Q2 2021 | $582,000 | -19.5% | 15,000 | 0.0% | 0.35% | -18.9% |
Q1 2021 | $723,000 | -7.3% | 15,000 | 0.0% | 0.43% | -4.5% |
Q4 2020 | $780,000 | -2.7% | 15,000 | -50.0% | 0.45% | +67.5% |
Q3 2020 | $802,000 | +174.7% | 30,000 | +100.0% | 0.27% | +52.3% |
Q2 2020 | $292,000 | +97.3% | 15,000 | 0.0% | 0.18% | +34.4% |
Q1 2020 | $148,000 | -11.4% | 15,000 | 0.0% | 0.13% | +8.3% |
Q4 2019 | $167,000 | +98.8% | 15,000 | 0.0% | 0.12% | +116.1% |
Q3 2019 | $84,000 | -35.4% | 15,000 | 0.0% | 0.06% | -29.1% |
Q2 2019 | $130,000 | +7.4% | 15,000 | 0.0% | 0.08% | +3.9% |
Q1 2019 | $121,000 | +95.2% | 15,000 | 0.0% | 0.08% | +28.8% |
Q4 2018 | $62,000 | -26.2% | 15,000 | 0.0% | 0.06% | +9.3% |
Q3 2018 | $84,000 | -57.4% | 15,000 | 0.0% | 0.05% | -59.7% |
Q2 2018 | $197,000 | – | 15,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |